In the past, CCTA scans in the United States were mainly used to avoid doing invasive angiograms when not needed. These scans are a noninvasive way to look closely at coronary arteries to find blockages or narrowing. Now, the role of CCTA is changing. Instead of only being a test before angiography, CCTA with AI is becoming a first step that gives detailed information about plaque and blood flow before any invasive procedure.
This change was talked about in a 2021 update to the American College of Cardiology (ACC) chest pain guidelines. AI tools, like HeartFlow’s algorithm, got a Class 1A recommendation. This means they are officially recognized as useful for planning procedures in detail. They can find where blood flow is blocked, measure the amount of plaque, and check the size of blood vessels—all important for deciding treatment.
Dr. Evan Scott Shlofmitz from St. Francis Hospital explains that AI helps heart teams plan better before patients go to the catheterization lab. This makes procedures shorter, avoids surprises during treatments, and helps doctors talk clearly with patients about how serious the disease is and what treatment options are available, including surgery if needed.
AI helps cardiology in other ways beyond planning procedures. The TRANSFORM trial, led by Dr. Deepak L. Bhatt and supported by Cleerly, looks at whether AI-enhanced CCTA is better than traditional heart disease risk calculators.
More than 7,000 patients at medium to high risk are in this study. It compares usual care to care based on CCTA scans with AI plaque analysis. The AI classifies plaques by how bad they are, from zero (no plaque) to three (severe plaque). This helps doctors decide how strong the treatment should be.
AI can find different types of plaques, including soft, lipid-rich plaques that can break apart and cause heart attacks. These soft plaques often do not show up on calcium scoring tests, which only find hard, calcified plaques. Finding these soft plaques early lets doctors give the right medicines and advice to help prevent heart attacks and strokes.
Dr. Bhatt thinks AI-augmented CCTA could become a common test in the future, like mammograms for breast cancer. He says current tools are not good enough to tell who needs the most care. AI may help by giving personalized risk based on large amounts of data.
For hospital leaders and practice owners, AI in heart imaging offers both medical and practical benefits. CCTA scans with AI provide detailed reports about the heart’s blood vessels and how well blood flows. This helps decide which patients need invasive procedures and which can be treated with medicines.
Better diagnosis accuracy lets heart teams make informed choices, which can lower the number of repeated tests and delays. This also makes patients happier and improves their recovery by cutting down hospital stays and lowering risks connected to invasive tests.
In terms of staff work, AI tools help radiologists and cardiologists by automatically processing complex images. This reduces the need for manual work and lets doctors spend more time on patient care. For IT and practice managers, this means faster test results and easier sharing of information in electronic health records.
HeartFlow’s technology automates processing CCTA scans and gives values called CT-FFR that show where blood flow is blocked. This helps plan treatments better, reduces surprises during procedures, and allows doctors to teach patients earlier about treatment options, which improves their understanding and willingness to follow plans.
Apart from medical improvements, AI helps office work and daily clinic operations. Medical practice administrators and IT managers can use AI to make their work smoother.
One important example is AI-powered phone systems. They help with scheduling appointments, reminding patients, and answering clinical questions. This lets staff focus on urgent tasks while keeping patients informed.
In radiology and cardiology imaging departments, AI automation helps by:
This setup leads to better teamwork between doctors and faster decision-making. Automating routine tasks also lowers costs and keeps care quality high.
Hospital leaders who invest in AI and automation can meet challenges like more patients, staff shortages, and demands for value-based care. These tools make administration more efficient and help manage heart disease using data.
Using AI in healthcare means paying attention to data quality and ethics. A review by Mohamed Khalifa and Mona Albadawy says AI works best when medical data is accurate, easy to access, and includes different groups of people. American hospitals using AI in CCTA need to keep data quality high.
Teams of doctors, data experts, technologists, and administrators must work together to build AI tools that really help in health care. AI systems need to be watched and updated to match new medical knowledge, reduce bias, and keep patients safe.
Good AI practices include being open about how decisions are made and protecting patient privacy. These are important to keep patients trusting when using AI tools for heart screening and predictions.
Medical leaders, healthcare owners, and IT managers in the U.S. face a choice with AI-enhanced CCTA technology. Using these tools can lead to more personalized and efficient heart care while improving both clinical work and administrative tasks. The role of AI in heart screening is growing, and early results show it can help improve care and clinic operations.
AI is transforming cardiology by automating coronary CT angiography (CCTA) analyses and assisting in pre-planning percutaneous coronary intervention (PCI) procedures.
HeartFlow’s technology analyzes CCTA scans to provide detailed insights into coronary anatomy, which helps cardiac teams plan interventions before entering the cath lab.
The analysis offers information on ischemia location, plaque composition, vessel diameter, optimal stent size, and potential complications.
CT scans now provide a wealth of data for procedural planning rather than serving merely as a gatekeeper for angiograms.
AI helps determine optimal angiographic views, assists in choosing treatment strategies, and saves procedure time.
AI provides detailed visualizations and risk assessments, allowing for informed discussions about treatment options with patients.
AI-enhanced insights sometimes enable discussions about CABG before even performing a diagnostic angiogram.
CCTA use has significantly increased after its endorsement in the 2021 ACC guidelines, recommending the use of HeartFlow’s algorithm.
HeartFlow’s algorithm was one of the first AI technologies included in medical society clinical guidelines, enhancing credibility and acceptance.
Advocates are pushing for CCTA to serve as a screening tool, utilizing AI to evaluate risks and potentially improve patient outcomes.